Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 10—October 2024
Dispatch
Oropouche Fever, Cuba, May 2024
Ana Julia Benitez1, Mayling Alvarez1, Lissette Perez, Rosario Gravier, Silvia Serrano, Denelsys Milagro Hernandez, Melissa Maria Perez, Gladys Gutierrez-Bugallo, Yanet Martinez, Ariamys Companioni, Carilda Peña, Jose Raul de Armas, Dayana Couto, Iliovanys Betancourt I, Madelaine Rivera Sanchez, Sonia Resik, Vivian Kouri, and Maria G. Guzman
Table 2
Clinical characteristics of patients with confirmed Oropouche fever, Cuba, 2024
| Clinical signs/symptoms |
No. (%) patients |
| Fever | 86 (86.9) |
| Headache | 71 (71.7) |
| General malaise | 51 (51.5) |
| Arthralgia | 22 (22.2) |
| Asthenia | 18 (18.1) |
| Anorexia | 16 (16.2) |
| Retroocular pain | 14 (14.1) |
| Abdominal pain | 8 (8) |
| Vomiting | 7 (7) |
| Diarrhea | 7 (7) |
| Chills | 4 (4) |
| Lumbar pain | 3 (3) |
1These authors contributed equally to this article.
Page created: September 03, 2024
Page updated: September 10, 2024
Page reviewed: September 10, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.